Weighing appearance against disease recurrence risk
Assessing CT scans in a 3-D virtual reality environment
Will cover over 500 imaging equipment assets
Models can be made in days
Device may prove especially valuable for cancer patients
Providing personalized attention to patients with chronic conditions
Complete with X-ray, ultrasound and CT scanner
May hold potential for use with targeted biopsies and radiotherapy
Identifying high-value imaging care pathways
Michael Linver on the importance of screening at 40
Reduces reading time by up to 29 percent
Bringing together core DR technologies in a highly compact design
Vantage Galan 3T MR and Aquilion ONE / GENESIS CT
Understanding patient anatomy before the operation
Cost is a major hurdle but affordable solutions are emerging
Patients generate 100 data points per hour
Bringing advanced ultrasound technology to out-of-hospital applications
Head exams are 68 percent faster than with previous generation
To be presented at RSNA annual meeting
Bringing the principles of telemedicine to imaging equipment technologists
Adherence to guidelines varies
Company also distributes system in other world markets
Calls for greater patient populations to receive the treatment
Bringing more definitive diagnosis to complex neurological disorders
A potential alternative to invasive biopsies in the future
Integrating data for more efficient care and physician time management
More personalized cancer treatment
Stroke rates of those who underwent ablation were similar to those without condition
A single scan is enough to make a diagnosis
"Important step" toward future of noninvasive temperature monitoring
Features some of the latest technological advancements
Suppressing a protein gets the job done
Reactors undergo life extension programs
Company continues to expand health care logistics portfolio
Philips doesn't have to pay $467 million jury verdict
Will ultrasound become the new standard?
Cleanings found 97.6 percent effective in study
What are the economics and what are your options?
Detects diffuse amyloid plaques — FDA-approved agents don’t
In N.C., group is 59 percent more likely to miss CDC exam guidelines
Using Watson Health to manage patient care more responsibly
Can reduce risk of stroke recurrence by 50 percent
Avoiding bottlenecks, reducing wait times, coordinating services and reducing risk
CorPath GRX will debut at conference this week
Should we be concerned?
MGH team combines analytics and imaging to make brain asymmetry a dementia biomarker
Will this be the end of this popular treatment?
Only one percent difference between digital and optical diagnosis
Even without major incidents, tackle football impacts brain function
Test distinguishes high risk of recurrence from low risk
